Cognitive Behavioral Therapy for Anxiety in Children
Trial Summary
What is the purpose of this trial?
Approximately 30% of children will experience an anxiety disorder, making anxiety the most common mental health problem among children in the United States. However, few children receive treatment and even our most effective anxiety treatments leave up to half of children in need of additional intervention. Despite the well-established role of parent anxiety in transmitting and maintaining child anxiety, the lack of data on specific parent mechanisms underlying the intergenerational transmission of anxiety is a critical barrier to informing novel targets of personalized treatments. Consistent with NIMH's Strategic Plan, Objective 2.2 to understand risk factors and behavioral indicators of mental illness across the lifespan and to identify novel intervention targets based on knowledge of psychological mechanisms, the current study focuses on interpretation bias, the tendency to perceive threat in ambiguous situations. The overall objective of this project is to empirically test a theoretical model of the intergenerational transmission of anxiety focused on parent interpretation bias as a root cause. Our specific aims are to test theorized effects of parent interpretation bias on (1) parent behavior and (2) child interpretation bias and (3) evaluate potential moderators to refine theories of intergenerational transmission of anxiety and inform future personalized interventions. Our central hypothesis is that parent interpretation bias influences child interpretation bias through its effects on maladaptive, anxiety-promoting parenting behaviors, such as accommodation and modeling of avoidant coping. To test this hypothesis, we will randomize 300 parents of children ages 7-12 to complete four weeks of a smartphone delivered interpretation bias manipulation vs. a self-assessment smartphone app condition. The interpretation bias intervention teaches parents to interpret ambiguous situations in a non-threatening manner via quick, repeated practice and corrective feedback. Before and after completing their randomly assigned condition, parent-child dyads will complete self-report and behavioral tasks designed to elicit anxiety-promoting behaviors from parents depending upon their interpretation of the ambiguous situation (speech and puzzle tasks). Parents will also complete Ecological Momentary Assessment (EMA) of parenting behaviors to capture the time course of effects. Finally, we will examine downstream effects of the interpretation manipulation on child interpretation bias at pre- and post- visits. We will test moderators (e.g., parent anxiety and gender) to refine theories of intergenerational transmission of anxiety and inform future personalized interventions. The long-term goal of this work is to inform personalized, mechanism-focused interventions to improve mental health outcomes for anxious children and their parents. Future studies will translate knowledge gained from this project into a scalable treatment that can be implemented entirely remotely via smartphone thereby increasing access to care
Will I have to stop taking my current medications?
The trial requires that if you are receiving treatment, you must be stable on your medications or therapy for at least 8 weeks before participating. This means you can continue your current medications as long as they have been stable for that period.
What data supports the effectiveness of the treatment HabitWorks, Lynparza, Self-Assessment, Self-Assessment Smartphone App for anxiety in children?
Research shows that cognitive behavioral therapy (CBT), which is a part of the treatment, is effective for reducing anxiety in children. Studies have found that both computer-assisted and internet-based CBT can help children manage anxiety, suggesting that similar approaches like HabitWorks and Self-Assessment Smartphone App might also be beneficial.12345
Is Cognitive Behavioral Therapy (CBT) safe for treating anxiety in children?
Research Team
Courtney Beard, PhD
Principal Investigator
Mclean Hospital
Eligibility Criteria
This trial is for parents with mild anxiety (GAD-7 score > 5) who have a child aged 7-12. They must own a smartphone, have some bias in interpreting ambiguous situations, and share custody of their child. Participants should not have severe psychiatric symptoms, intellectual disabilities or autism in the family, or severe suicidal thoughts.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Parents complete four weeks of a smartphone-delivered interpretation bias manipulation or a self-assessment app condition
Follow-up
Participants are monitored for changes in parent and child interpretation bias and parent behavior
Treatment Details
Interventions
- HabitWorks
- Self-Assessment
HabitWorks is already approved in European Union, United States for the following indications:
- Breast cancer
- Ovarian cancer
- Fallopian tube cancer
- Peritoneal cancer
- Pancreatic cancer
- Prostate cancer
- Endometrial cancer
- Ovarian, fallopian tube, and primary peritoneal cancer
- Breast cancer
- Prostate cancer
- Pancreatic cancer
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mclean Hospital
Lead Sponsor